Technology area: Biotechnology & Pharmaceuticals
22 pending office actions • 21 art units • 22 examiners • 0 of 22 (0%) have an AI response strategy ready • 26 patents granted in the last 365 days
University of Georgia Research Foundation Inc. has 22 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 22 distinct examiners and span 21 distinct art units, showing an exceptionally dispersed examination structure within the reported technology area.
ROBINSON, KEITH O NEAL is the busiest examiner, with 1 pending matter. No examiner appears to control a meaningful share of the docket, so counsel should organize prosecution around individual inventions and art-unit requirements. A centralized review of recurring biotechnology claim issues may still improve consistency, but examiner-specific precedent or interview leverage is unlikely to apply broadly based on these assignment figures.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 5 (23%) |
| §103 only | 6 (27%) |
| Double-patenting + other | 2 (9%) |
| Multi-statute (no §101) | 9 (41%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBINSON, KEITH O NEAL | 1 | 91.6% | +3.8% |
| PURDY, KYLE A | 1 | 41.0% | +35.7% |
| HAUK TEODORO, PRICILA NMN | 1 | 50.0% | +0.0% |
| RUSH, ERIC | 1 | 60.8% | +36.2% |
| SONG, JIANFENG | 1 | 56.4% | +33.0% |
| KWON, JOHN SEUNGJAI | 1 | 44.9% | +20.2% |
| BLUMEL, BENJAMIN P | 1 | 70.7% | +30.6% |
| DEVI, SARVAMANGALA | 1 | 65.5% | +55.5% |
| PIPIC, ALMA | 1 | 54.8% | +54.3% |
| PROSSER, ALISSA J | 1 | 15.5% | +11.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18503100 | COMPOSITIONS AND METHODS FOR MAKING PARASYMPATHETIC NEURONS | JACKSON III, WALTER | 31d overdue |
| 19192111 | ENGINEERING TOMATO FRUITS AS A PRODUCTION PLATFORM FOR TERPENOID PRODUCTS | ROBINSON, KEITH O NEAL | — |
| 19178982 | SURFACES AND COATING COMPOSITIONS HAVING ANTIFOULING, ANTITHROMBOTIC, AND ANTIBACTERIAL PROPERTIES AND METHODS OF MAKING | PURDY, KYLE A | — |
| 19085932 | IMMUNOGENIC ANTI-FUNGAL POLYPEPTIDES, COMPOSITIONS AND METHODS THEREOF | HAUK TEODORO, PRICILA NMN | — |
| 19109526 | PAVEMENT MANAGEMENT SYSTEM USING SATELLITE DATA AND MACHINE LEARNING | RUSH, ERIC | — |
| 18849109 | A NOVEL H1N1 ANTIBODY | BLUMEL, BENJAMIN P | — |
| 18846326 | LIVE MYCOPLASMA SYNOVIAE VACCINE | DEVI, SARVAMANGALA | — |
| 18833322 | RADIOSENSITIZING COMPOSITIONS AND METHODS OF USE THEREOF | PIPIC, ALMA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19178982 | SURFACES AND COATING COMPOSITIONS HAVING ANTIFOULING, ANTITHROMBOTIC, AND ANTIBACTERIAL PROPERTIES AND METHODS OF MAKING | PURDY, KYLE A | — |
| 19109526 | PAVEMENT MANAGEMENT SYSTEM USING SATELLITE DATA AND MACHINE LEARNING | RUSH, ERIC | — |
| 18990391 | NANOPARTICLES FOR PREVENTING PERI/POST-MENOPAUSAL BONE LOSS AND/OR OBESITY | SONG, JIANFENG | — |
| 18923765 | COMPOSITIONS AND ARTICLES FOR DELIVERING NITRIC OXIDE AND METHODS FOR MAKING AND USING THE SAME | KWON, JOHN SEUNGJAI | — |
| 18849109 | A NOVEL H1N1 ANTIBODY | BLUMEL, BENJAMIN P | — |
| 18846326 | LIVE MYCOPLASMA SYNOVIAE VACCINE | DEVI, SARVAMANGALA | — |
| 18833322 | RADIOSENSITIZING COMPOSITIONS AND METHODS OF USE THEREOF | PIPIC, ALMA | — |
| 18682184 | ANTIBACTERIAL PORPHYRIN NANOPARTICLES AND METHODS FOR MAKING AND USING THE SAME | PROSSER, ALISSA J | — |
| Art Unit | Apps |
|---|---|
| 1645 | 2 |
| 1661 | 1 |
| 1611 | 1 |
| 2677 | 1 |
| 1613 | 1 |
| 1615 | 1 |
| 1671 | 1 |
| 1617 | 1 |
| 1619 | 1 |
| 2871 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19192111 | ENGINEERING TOMATO FRUITS AS A PRODUCTION PLATFORM FOR TERPENOID PRODUCTS | ROBINSON, KEITH O NEAL | 1661 | §101§103§112Other | Non-Final OA | — | Pending | Apr 28, 2025 |
| 19178982 | SURFACES AND COATING COMPOSITIONS HAVING ANTIFOULING, ANTITHROMBOTIC, AND ANTIBACTERIAL PROPERTIES AND METHODS OF MAKING | PURDY, KYLE A | 1611 | §102§103§112Other | Non-Final OA | — | Pending | Apr 15, 2025 |
| 19085932 | IMMUNOGENIC ANTI-FUNGAL POLYPEPTIDES, COMPOSITIONS AND METHODS THEREOF | HAUK TEODORO, PRICILA NMN | 1645 | §103§112 | Non-Final OA | — | Pending | Mar 20, 2025 |
| 19109526 | PAVEMENT MANAGEMENT SYSTEM USING SATELLITE DATA AND MACHINE LEARNING | RUSH, ERIC | 2677 | §101§103§112 | Non-Final OA | — | Pending | Mar 06, 2025 |
| 18990391 | NANOPARTICLES FOR PREVENTING PERI/POST-MENOPAUSAL BONE LOSS AND/OR OBESITY | SONG, JIANFENG | 1613 | §103§112DP | Non-Final OA | — | Pending | Dec 20, 2024 |
| 18923765 | COMPOSITIONS AND ARTICLES FOR DELIVERING NITRIC OXIDE AND METHODS FOR MAKING AND USING THE SAME | KWON, JOHN SEUNGJAI | 1615 | §102§103§112DP | Non-Final OA | — | Pending | Oct 23, 2024 |
| 18849109 | A NOVEL H1N1 ANTIBODY | BLUMEL, BENJAMIN P | 1671 | §102§112Other | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18846326 | LIVE MYCOPLASMA SYNOVIAE VACCINE | DEVI, SARVAMANGALA | 1645 | §101§102§112 | Non-Final OA | — | Pending | Sep 12, 2024 |
| 18833322 | RADIOSENSITIZING COMPOSITIONS AND METHODS OF USE THEREOF | PIPIC, ALMA | 1617 | §103§112 | Non-Final OA | — | Pending | Jul 25, 2024 |
| 18682184 | ANTIBACTERIAL PORPHYRIN NANOPARTICLES AND METHODS FOR MAKING AND USING THE SAME | PROSSER, ALISSA J | 1619 | §103 | Final Rejection | — | Pending | Feb 08, 2024 |
| 18428342 | Light Sheet Microscopy | LAU, EDMOND C | 2871 | §102§103§112 | Non-Final OA | — | Pending | Jan 31, 2024 |
| 18577631 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS | BELL, SARA ELIZABETH | 1625 | §102§103§112 | Non-Final OA | — | Pending | Jan 08, 2024 |
| 18528067 | BROADLY REACTIVE VIRAL ANTIGENS AS IMMUNOGENS, COMPOSITIONS AND METHODS OF USE THEREOF | CHEN, STACY BROWN | 1672 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18562997 | BIODEGRADABLE IMPLANTS WITH ANTICORROSIVE COATINGS CONTAINING SILK FIBROIN | BOWMAN, ANDREW J | 1717 | §103 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18561613 | NITRIC OXIDE-RELEASING DISINFECTION INSERT | SPAMER, DONALD R | 1799 | §103 | Non-Final OA | — | Pending | Nov 16, 2023 |
| 18503100 | COMPOSITIONS AND METHODS FOR MAKING PARASYMPATHETIC NEURONS | JACKSON III, WALTER | 1638 | §103§112 | Final Rejection | 31d overdue | Pending | Nov 06, 2023 |
| 18242921 | METHODS AND SYSTEMS FOR PHOSPHORMER MODEL EVALUATION | KRIANGCHAIVECH, KETTIP | 1686 | §101§102§112 | Non-Final OA | — | Pending | Sep 06, 2023 |
| 17596351 | TELMISARTAN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE IN DOGS | CHONG, YONG SOO | 1623 | §103 | Non-Final OA | — | Pending | Dec 08, 2021 |
| 17514795 | DYNAMIC POLYMER SURFACES FOR SCREENING, ENRICHMENT, AND HARVESTING OF CELLS AND OTHER SOFT COLLOIDAL PARTICLES | KWAK, DEAN P | 1798 | §102§103§112 | Non-Final OA | — | Pending | Oct 29, 2021 |
| 17434909 | REACTIVE ELECTROCHEMICAL MEMBRANE SYSTEM AND METHODS OF MAKING AND USING | JEBUTU, MOFOLUWASO SIMILOLUWA | 1795 | §102§103 | Non-Final OA | — | Pending | Aug 30, 2021 |
| 17427528 | CONTACTLESS MONITORING OF SLEEP ACTIVITIES AND BODY VITAL SIGNS VIA SEISMIC SENSING | FEDORKY, MEGAN TAYLOR | 3796 | §103 | Non-Final OA | — | Pending | Jul 30, 2021 |
| 17421069 | TARGETED NANOPARTICLES AND THEIR USES RELATED TO FUNGAL INFECTIONS | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Final Rejection | — | Pending | Jul 07, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Georgia Research Foundation Inc. has 22 pending office actions as of October 2026, spread across 21 art units and 22 examiners.
Keith O Neal Robinson has the most, with 1 of University of Georgia Research Foundation Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
